B&K CORP-B(02396.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 121.92 million, loss widened by 40.65% YoY
NewTimeSpace News: August 14, 2026, B&K CORP-B(02396.HK) released its Interim Report for the period ended December 31, 2026; Net Profit stood at loss of CNY 121.92 million, loss widened by 40.65% YoY; Profit Attributable to Shareholders stood at loss of CNY 121.92 million, loss widened by 40.65% YoY; Basic Earnings Per Share (EPS) stood at loss of CNY 1.04.
NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- HK shares Newly Listed Stocks Tracking Weekly Report: B&K CORP-B Leads with 68% Weekly Gain; INNOGEN-B Down Over 45% Cumulatively in Two Weeks Since Lock-up Expiry - 20260821
- B&K CORP-B (02396.HK): Chinese Corporate Name Changed from Huaren Bio-B to Qingcheng New Drug-B, New Stock Short Name Effective from 22 July
- NewTimeSpace | Hong Kong’s “first PDGF stock” frozen out by capital markets: B&K CORPORATION LIMITED (02396.HK) has lost more than 70% since listing
